Tirzepatide TFA

Tirzepatide TFA

Cat. No.: DIA-0243373

Size: 50 mg Size: 100 mg Size: 250 mg Size: Customer Size
Product Information
Synonyms LY3298176 TFA
Formula C227H349F3N48O70
Molecular Weight 4927.47
Target GLP Receptor
Product Description Tirzepatide TFA (LY3298176 hydrochloride) is a glucose-dependent insulin nutritive polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor dual agonist. Tirzepatide TFA has neuroprotective effects and can be used in the study of type 2 diabetes, diabetes-related neuropathy and obesity.
Format & Storage
Format Solid
Color White to off-white
Shipping Room temperature in the continental U.S. Other areas may vary.
Storage In solvent: -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
All of our services and products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
logo

Ace Therapeutics has a team of experts in the field of endocrine and metabolic research, aiming to provide innovative preclinical contract research solutions to cope with diabetes and its complications. We provide customized solutions and technical support, enabling the transformation of promising concepts into innovative treatments, thus accelerating the drug development process of diabetes.

Quick Links
Contact Info
Copyright © Ace Therapeutics. All Rights Reserved.
Top